Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul:33:314-9.
doi: 10.1016/j.meegid.2015.05.022. Epub 2015 May 21.

First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in Guinea

Affiliations

First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in Guinea

Mebrat Ejo et al. Infect Genet Evol. 2015 Jul.

Abstract

In this study we assessed first-line anti-tuberculosis drug resistance and the genotypic distribution of Mycobacterium tuberculosis complex (MTBC) isolates that had been collected from consecutive new tuberculosis patients enrolled in two clinical trials conducted in Guinea between 2005 and 2010. Among the total 359 MTBC strains that were analyzed in this study, 22.8% were resistant to at least one of the first line anti-tuberculosis drugs, including 2.5% multidrug resistance and 17.5% isoniazid resistance, with or without other drugs. In addition, further characterization of isolates from a subset of the two trials (n = 184) revealed a total of 80 different spoligotype patterns, 29 "orphan" and 51 shared patterns. We identified the six major MTBC lineages of human relevance, with predominance of the Euro-American lineage. In total, 132 (71.7%) of the strains were genotypically clustered, and further analysis (using the DESTUS model) suggesting significantly faster spread of LAM10_CAM family (p = 0.00016). In conclusion, our findings provide a first insight into drug resistance and the population structure of the MTBC in Guinea, with relevance for public health scientists in tuberculosis control programs.

Keywords: Genotypes; Guinea; Resistance; Spoligotyping; Tuberculosis.

PubMed Disclaimer

References

    1. Adegbola R.A., Hill P., Baldeh I., Otu J., Sarr R. Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int. J. Tuberc. Lung Dis. 2003;7:390–393. - PubMed
    1. Affolabi D., Anyo G., Faihun F., Sanoussi N., Shamputa I.C. First molecular epidemiological study of tuberculosis in Benin. Int. J. Tuberc. Lung Dis. 2009;13:317–322. - PubMed
    1. Ani A., Bruvik T., Okoh Y., Agaba P., Agbaji O. Genetic diversity of Mycobacterium tuberculosis complex in Jos. Nigeria BMC Infect. Dis. 2010;10:189. - PMC - PubMed
    1. Bang D., Andersen P.H., Andersen A.B., Thomsen V.O. Isoniazid-resistant tuberculosis in Denmark: mutations, transmission and treatment outcome. J. Infect. 2010;60:452–457. - PubMed
    1. Ben Amor Y., Nemser B., Singh A., Sankin A., Schluger N. Underreported threat of multidrug-resistant tuberculosis in Africa. Emerg. Infect. Dis. 2008;14:1345–1352. - PMC - PubMed

Publication types

MeSH terms

Substances